Health & Biotech
ASX Health Stocks: Clarity Pharma shows effectiveness in diagnosing prostate lesions in Phase 1 trial
ASX Health Stocks: Emyria surges another 10pc; cannabis play Vitura delivers record profit
ScoPo’s Powerplays: ASX health stocks fall but cap raises show money flowing into sector
PharmAust reports extension of survival time and quality of life from MPL trial for dogs with B-cell lymphoma
CardieX Raises $4.5 million as it gears up for dual US listing as CONNEQT Pulse awaits FDA Clearance
Dimerix ticks another box in its Action3 Phase-3 FSGS kidney trial
ASX Health Stocks: Argenica rockets by 30pc after showing potential breakthrough on Alzheimer’s
The chances of Phase 3 success, and the ASX health stocks that are close to a home run
Weed Week: Greens reckon legal cannabis could generate $28 billion over a decade
ASX Health Stocks: INOVIQ says its breast cancer technology beats currently available tests
Creso Pharma subsidiary Halucenex Life Sciences eyes Aussie market entry following landmark TGA decision
ASX Health Stocks: Creso eyes psychedelic spinout off the back of landmark TGA decision
New Aussie biotech Filamon aims to stop cancer progressing to a lethal disease
Australia just became the first country to recognise psychedelics as medicine. These are the ASX stocks you need to know about
After a successful $4.5 million cap raise and with cancer trial results to come, Kazia is optimistic for 2023
ScoPo’s Powerplays: ASX health stocks rise, Mach 7 lands largest contract and posts record quarter
ASX Health Stocks: GTG jumps 30pc as it launches world’s first comprehensive breast and ovarian cancer test
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
